Mirtazapine and the granulocytes--so far so good.
Meyboom
R H
RH
Edwards
I R
IR
Egberts
A C
AC
D016907:Adverse Drug Reaction Reporting Systems; D000380:Agranulocytosis / Q000139:chemically induced*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D009520:New Zealand; D012702:Serotonin Antagonists / Q000009:adverse effects*; D014944:World Health Organization
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D012702:Serotonin Antagonists; D008803:Mianserin; D000078785:Mirtazapine